Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy

PURPOSE: Approximately 7% of patients with newly diagnosed prostate cancer (PCa) in the US will have have metastatic disease. The dogma that there is no role for surgery in this population has been questioned recently. Here we report long-term outcomes of a phase 1 clinical trial on cytoreductive ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Isaac Yi, Mitrofanova, Antonina, Panja, Sukanya, Sterling, Joshua, Srivastava, Arnav, Kim, Juliana, Kim, Sinae, Singer, Eric A., Jang, Thomas L., Ghodoussipour, Saum, Saraiya, Biren, Mayer, Tina, Sabaawy, Hatem E., Yuh, Bertram, Byun, Seok Soo, Kim, Wun-Jae, Horie, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035380/
https://www.ncbi.nlm.nih.gov/pubmed/35510081
http://dx.doi.org/10.1016/j.prnil.2022.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035380/
https://www.ncbi.nlm.nih.gov/pubmed/35510081
http://dx.doi.org/10.1016/j.prnil.2022.03.001

Ejemplares similares